Induction chemotherapy is the best timekeeper in nasopharyngeal carcinoma

Cancer. 2020 Aug 15;126(16):3624-3626. doi: 10.1002/cncr.32971. Epub 2020 Jun 4.

Authors

Stefano Cavalieri¹, Lisa Licitra^{1

2}

Affiliations

¹ Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
² Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.

PMID: 32497251
DOI: 10.1002/cncr.32971

No abstract available

Keywords: EBV; NPC; induction chemotherapy; nasopharyngeal carcinoma; neoadjuvant chemotherapy.

Publication types

Editorial

MeSH terms

Epstein-Barr Virus Infections / drug therapy*
Epstein-Barr Virus Infections / epidemiology
Epstein-Barr Virus Infections / virology
Herpesvirus 4, Human / pathogenicity
Humans
Induction Chemotherapy*
Nasopharyngeal Carcinoma / drug therapy*
Nasopharyngeal Carcinoma / epidemiology
Nasopharyngeal Carcinoma / virology
Nasopharyngeal Neoplasms / drug therapy*
Nasopharyngeal Neoplasms / epidemiology
Nasopharyngeal Neoplasms / virology